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Abstract: In Ecuador, a national program for bovine brucellosis control has been in implementation
since 2008. Given the costs, small- and medium-sized livestock holders are not completely committed
to it. The objective of this study was to determine true prevalence (TP) of bovine brucellosis in
small- and medium-sized herd populations, as well as the diagnostic sensitivity and specificity of
the Rose Bengal (RB) test and the sero-agglutination test (SAT)-EDTA using a Bayesian approach.
Between 2011 and 2016, 2733 cattle herds were visited, and 22,592 animal blood samples were
taken in nineteen provinces on mainland Ecuador. Bayes-p and deviance information criterion
(DIC) statistics were used to select models. Additionally, risk-factor analysis was used for herds
according to their brucellosis test status. True prevalence (TP) in herds was estimated by pool testing.
National seroprevalence of farms was 7.9% (95% CI: 6.79–9.03), and TP was 12.2% (95% CI: 7.8–17.9).
Apparent prevalence (AP) in animals was 2.2% (95% CI: 1.82–2.67), and TP was 1.6% (95% CrI:
1.0–2.4). Similarly, the sensitivity of the RB was estimated at 64.6% (95% CrI: 42.6–85.3) and specificity
at 98.9% (95% CrI: 98.6–99.0); for the SAT-EDTA test, sensitivity was 62.3% (95% CrI: 40.0–84.8) and
98.9% (95% CrI: 98.6–99.1) for specificity. Results of the two tests were highly correlated in infected
and uninfected animals. Likewise, high spatial variation was observed, with the Coastal Region
being the zone with the highest TP at 2.5%. (95% CrI: 1.3–3.8%) in individual animals and 28.2%
(95% CI: 15.7–39.8) in herds. Risk factors include herd size, type of production (milk, beef, and
mixed), abortions recorded, and vaccination. The results of this study serve to guide authorities to
make decisions based on parallel testing at the beginning of a bovine brucellosis program for small
livestock holders to increase sensitivity level of the screening tests in Ecuador.
Keywords: bovine; modelling; brucellosis; diagnosis; sensitivity; specificity; true prevalence; Bayes
1. Introduction
Bovine brucellosis is a highly contagious disease caused by Brucella abortus, less
frequently by Brucella melitensis, and rarely by Brucella suis. The importance of this disease
corresponds to its great economic impact on the livestock industry and serious risks related
to human health [1].
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Since 2008, Ecuador has a national program for the control of bovine brucellosis [2],
which has contributed to reducing its prevalence. However, given its non-mandatory
implementation and the high costs that owners must face for the diagnosis of the disease
in animals, small- and medium-sized livestock holders (more than 80% of the producers
in Ecuador) tend to not be involved in the program [3]. Likewise, Carbonero et al. [4]
estimated the brucellosis seroprevalence in dairy and mixed cattle from semi-extensive
systems in Ecuador as approximately 17.0% in individual animals and 45.1% at herd
level. They used Rose Bengal (RB) and blocking ELISA tests for these analyses. Factors
such as gender, dairy-herd type, closed facilities, non-ad libitum (restricted) feeding, age,
average slope, and annual abortion rates were recognized as risk factors for the presence
of seropositivity in cattle herds of Ecuador. In addition, Poulsen et al. [5] estimated an
apparent prevalence of 5.5% and a true prevalence (TP) of 7.2% in animals based on a RB test.
They determined higher prevalence of bovine brucellosis in commercial herds compared to
smaller groups (of less than five animals). In conclusion, both studies stated that the overall
prevalence is similar to other estimates obtained in cattle herds. Furthermore, in 1979,
the National Animal Health Program (PNSA) of Ecuador carried out a serological survey
to investigate the prevalence of bovine brucellosis, where 15,393 bovines were sampled.
Using the rapid plate agglutination test, they obtained a seroprevalence of 6% (95% CI:
1.3–10) in Ecuador, ranging from 1.97% to 10.62% in cattle in the provinces of the Northern
Highlands, from 4.12% to 10.62% in the Coastal Provinces, and from 1.3% to 2.6% in the
provinces of the Southern Highlands [6]. The Ecuadorian Agency for Quality Assurance
(Agrocalidad) together with a variety of representatives of organized milk producers and
industrialists estimated that seroprevalence of brucellosis in animals from 1979 to 2008 is
estimated at 3.30% [6]. Unpublished data obtained from distinct Ecuadorian universities
show significant variability in cattle disease prevalence, ranging from 1–9.73% to 24–48% [5].
Thus, the estimation at both national and local levels might depend on the tests used, the
testing strategy (e.g., serial or parallel testing procedure), and the sampling size [7]. For an
effective surveillance of bovine brucellosis, reliable diagnostic tests must be used. Bacterial
culture and isolation of the bacteria should be used to confirm (gold standard) the disease
and determine which species or biovars of Brucella are causing it. However, the causative
agent is a slow-growing microorganism. Therefore, the probability of recovering it is
relatively low (around 20% in individuals with brucellosis) [8,9]. Additionally, the high
costs, requirement of qualified personnel, and the need for high-security laboratories must
be taken into consideration. [8,10,11]. In the absence of bacterial culture, several different
serological tests offer a practical media for diagnosis. Furthermore, given that all tests have
limitations, OIE recommends the use of multiple types of serological test for brucellosis
diagnosis. Carrying out simultaneous serological tests to confirm the disease increases the
sensitivity (Se) level and reduces the percentage of false negatives [12–14].
Due to all these drawbacks, screening populations in control programs requires the
use of combined serological tests. Serological tests, such as RB and SAT, in the presence
of EDTA might contribute to a rapid and practical diagnosis of brucellosis, given the
possibility of exploring several kinds of antibodies [1,15–17]. The serum agglutination
test (SAT) and the Rose Bengal test (RB) are commonly used for brucellosis screening
in control and eradication programs. The Rose Bengal test is often used as a rapid and
inexpensive screening test [15,16]. It is based on the agglutination of serum IgG antibodies
with a preparation of whole cells stained with dead Brucella. RB has been used in the
conventional and mass diagnosis of brucellosis. For confirmation of RB, SAT can be used in
more sophisticated laboratories in addition to an enzyme immunoassay test (ELISA) [13,17].
SAT-EDTA particularly offers the possibility of detecting IgM for initial exposure [18].
Nevertheless, for massive programs of control, it is necessary to know the baseline
of the disease; therefore, inexpensive, but reliable testing is necessary. A classic Rogan–
Gladen equation is usually used to estimate the disease prevalence; unfortunately, it
requires constant values and a prior knowledge of test sensibility (Se) and specificity
(Sp), which may be unrealistic in practice. In Ecuador, very little is known about the test
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characteristics operating during brucellosis studies. In the two previous studies carried
out in Ecuador [4,5], values for Se and Sp were reported given by the manufacturer or by
literature estimates, respectively, with values of 98% and 99.9% for blocking ELISA, and
72.2% and 99.6% for the Rose Bengal test. These values were used to estimate the TP in
Ecuador. On the other hand, Ron-Román et al. [18] reported sensitivities values for ELISA,
RB, and SAT-EDTA tests in human samples of Ecuador with values around of 95.1%, 95.0%,
and 60.8%, respectively. Specificity for these tests was >99.0%, but for SAT-EDTA, it was
higher than 99.9%.
For this analysis, a Bayesian approach was used. Bayesian analysis involves calculat-
ing from a prior probability distribution and data likelihood, a posterior probability for the
parameters of a given model [19,20]. Currently, the Bayesian approach is widely used for
estimating the disease prevalence and the diagnostic characteristics of the tests (Se and Sp)
jointly and in the absence of a gold standard test [21].
The present study aims to estimate the apparent and true prevalence of bovine brucel-
losis in small- and medium-sized livestock holders in Ecuador, as well as to determine the
characteristics of two diagnostic tests (Se and Sp) for RB and SAT-EDTA. Another aim was
to identify the risk factors that predispose the presence of this disease in Ecuadorian cattle
farms in order to formulate some recommendations for the national control program of
bovine brucellosis [22]. All these results of this study will improve Ecuador’s public health
and livestock economy by encouraging the consideration and implementation of effective
brucellosis control strategies, based on national data, since elaborating programs cannot be
created based on the extrapolation of international data [23].
2. Materials and Methods
2.1. Description of the Study
This cross-sectional study was part of the brucellosis, tuberculosis, and cattle ticks
national survey that started in 2012 and ended in 2015 on mainland Ecuador [24]. The
study population consisted of agricultural productive units (farms) that raise cattle, with
an emphasis on small and medium herds. The bovines were selected by random sampling
in small, medium, and large farms belonging to 19 of the 24 provinces in Ecuador. The
selection of the number of animals to sample by province was carried out by taking into
account the number of animals that the province contributes to the national total of animals
(weighting). Both female bovines (with or without RB51 vaccine) and male bovines older
than 6 months were sampled. Female bovines vaccinated with Strain 19 that were older
than 18 months were also sampled [25].
The animals were sampled without distinction of the breed, choosing a proportion
according to the number of animals present on each farm: 4–6 animals (75%), 7–15 animals
(50%), 16–30 animals (33%), 31–80 animals (29%), 81–160 animals (25%), and more than
160 animals (40 animals) [26]. Blood samples were taken from 22,592 animals, belonging to
2733 livestock farms, which were classified as large (more than 70 cattle), medium (21 to
70 cattle), and small (1 to 20 cattle).
Cattle farms corresponding to 19 provinces, which were classified into regions: the
Coastal Region (Esmeraldas, Guayas, Los Ríos, Manabí, Santa Elena, and Sto. Domingo),
the Northern Highlands (Bolívar, Carchi, Chimborazo, Cotopaxi, Imbabura, Pichincha,
and Tungurahua), the Southern Highlands (Azuay, El Oro, Loja, and Zamora Chinchipe),
and the Amazon Region (Napo and Pastaza). This classification takes into account similar
production systems and the provincial population size of the herds. The sampled provinces
are shown in Table 1.
To evaluate the risk factors, an epidemiological survey was applied on each farm, which
consisted of a personal interview with the people in charge. This questionnaire included
aspects related to the identification and location of the farm, general data (number of animals
and production type), and sanitary aspects (reproduction system, abortion management,
veterinary control, clinical manifestations of the disease, diagnosis, and vaccination).
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Table 1. Farms samples.
Parameter
Sample Positive **
N◦ % Mean * N◦ % Mean *
COASTAL REGION (Animals) 9355 42.28 13.08 310 65.13 2.33
COASTAL REGION (APUs) 715 26.16 - 133 61.29 -
Large Farms 165 6.03 - 61 28.11 -
Medium Farms 325 11.89 - 57 26.27 -
Small Farms 212 7.76 - 12 5.53 -
Not reported 13 0.48 - 3 1.38 -
NORTHERN HIGHLANDS (Animals) 6880 31.09 5.6 139 29.2 1.96
NORTHERN HIGHLANDS (APUs) 1229 44.97 - 71 32.72 -
Large Farms 52 1.91 - 11 5.07 -
Medium Farms 175 6.4 - 23 10.6 -
Small Farms 985 36.04 - 36 16.59 -
Not reported 17 0.62 - 1 0.46 -
SOUTHERN HIGHLANDS (Animals) 4767 21.54 7.13 11 2.31 1.38
SOUTHERN HIGHLANDS (APUs) 669 24.48 - 8 3.69 -
Large Farms 30 1.1 - 0 0 -
Medium Farms 175 6.4 - 3 1.38 -
Small Farms 410 1.5 - 3 1.38 -
Not reported 40 1.47 - 1 0.46 -
AMAZON REGION (Animals) 1124 5.08 9.37 16 3.36 3.2
AMAZON REGION (APUs) 120 4.39 - 5 2.3 -
Large Farms 3 0.11 - 1 0.46 -
Medium Farms 59 2.16 - 1 0.46 -
Small Farms 55 2.01 - 3 1.38 -
Not reported 3 0.11 - 0 0 -
Total General (Animals) 22,126 100 8.1 476 100 2.19
Total General (APUs) 2733 100 - 217 100 -
Legend: AUP, animal unit production; Mean * = mean number of animals per APU (sampled or positive); ** an animal is considered
positive when at least one test result was positive (parallel interpretation).
2.2. Diagnostic Assays
Blood samples were collected from each animal by coccygeal venipuncture. The
samples were labeled and transported to the laboratory on ice (4–8 ◦C) after clotting. The
blood serum obtained by centrifugation (250 rpm) was processed and analyzed in the
immunodiagnostic laboratory at the International Zoonoses Institute (CIZ) at the Central
University of Ecuador. The screening tests used to determine the presence of antibodies
against Brucella spp. were RB and the serum agglutination test in the presence of EDTA
(SAT-EDTA) with a cut-off point above 30 IU (International Units) (25% of agglutination
for the dilution 1/25), according to OIE and Sciensano protocols. Unidentified, hemolyzed,
icteric, lipemic, and contaminated samples were discarded [27] and labelled as “Not
Reported” (NR); samples of animals that had an NR result in both RB and SAT-EDTA were
discarded. Finally, a cured database was obtained with the results of 22,126 animals (97.9%
sampled) belonging to 2733 farms (100% sampled).
2.3. Statistical Analysis
Apparent prevalence at animal level: this was calculated for the two tests using
parallel interpretation; 95% interval confidence for the proportion estimation was obtained.
Parallel interpretation: An animal was considered positive when at least one of the
tests gave a positive result. That is, it was sufficient that one of the tests was positive in
order to declare that animal as sick, regardless of the information provided by the other
tests [28,29]. Parallel tests increased Se and negative predictive value (NPV) and decreased
Sp and positive predictive value (PPV) [30,31].
True prevalence at animal level and test characteristics: Two Bayesian frameworks,
probabilistic constraints [32] and co-variances between tests [33], were created to estimate
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this prevalence. Functions truePrevMulti and truePrevMulti2 from the Prevalence Pack-
age [34] were used for this propose under R environment 3.5.2 [35]. The two models were
used to calculate the true prevalence and the test characteristics. Likewise, evaluation of
test co-variances for the truly infected and uninfected animals under Model 2 Markov
Chain Monte Carlo (MCMC) was done by using the freeware program WinBUGS 1.4.3 [36]
(Appendix A-Table A1).
For the first model, which used a conditional probability scheme, a total of 7 pa-
rameters (θi) were required [32,34]. Prior information on the prevalence of brucellosis in
Ecuador [3,6] and the characteristics of RB, sensitivity and specificity [37], was obtained
from several previous studies. The parameters used in this model were:
θ1 = TP = P(D+) ; θ2 = SeRB = P(T+1




∣∣D− ∩ T−1 ; θ6 = P(T+2 ∣∣ D+ ∩ T−1 ) and θ7 = P(T−2 ∣∣ D− ∩ T+1 )
where P = probability; D+ = animals with brucellosis; D− = healthy animals;
T+1 = positive animals to the RB; T
−
1 = negative animals to the RB; T
+
2 = positive animals to the
SAT-EDTA; T−2 = negative animals to the SAT-EDTA. For some parameters (θ4, θ5, θ6, θ7), it
was not possible to obtain objective prior information. Therefore, it was necessary to consider
the previous information on these parameters as “non-informative” (Table 2).
Table 2. Prior information used for sensitivity and specificity of RB and SAT and prevalence in Ecuador used in Models 1 and 2.
MODEL 1 MODEL 2
REFERENCES
Parameter Value Distribution Parameter Value Distribution
theta [1] 3% Beta = (16, 486) TP 3% Beta = (16, 486) [3]
theta [2] 72% Beta = (16, 6) SE [1] 72% Beta = (16, 6) [37]
theta [3] 71–99% Uniform = (0.71, 0.99) SP [1] 71–99% Uniform = (0.71, 0.99) [37]
theta [4] NI Uniform = (0.00, 1.00) SE [2] 50–99% Uniform = (0.50, 0.99) [2,38]
theta [5] NI Uniform = (0.00, 1.00) SP [2] 90–100% Uniform = (0.90, 1.00) [38]
theta [6] NI Uniform = (0.00, 1.00) a [1] NI Uniform = (0.00, 0.25) -
theta [7] NI Uniform = (0.00, 1.00) b [1] NI Uniform = (−0.25, 0.25) -
Legend: NI = non-informative.
For the second model, which used a covariance scheme between tests [34], seven
parameters were required. The model construction strategy consisted of incorporating
prior information on the prevalence of brucellosis in Ecuador [3,6] and on the characteristics
of the RB, sensitivity and specificity [37], and SAT-EDTA, sensitivity and specificity [38],
which were obtained from several previous studies (Table 2). The parameters used in this
model were:
θ1 = TP; θ2 = SeRB; θ3 = SpRB; θ4 = SeSAT−EDTA = P(T+2 |D+); θ5 = SpSAT−EDTA = P(T
−
2 | D−);
Cov (T1, T2| D+) = a = θ2θ4 − (θ2(θ2θ4 + θ5 − θ2θ5)) and Cov (T1, T2| D−) = b = (1− θ3)−
((1− θ3)(1− θ7 + θ3θ7 − θ3θ6)).
Due to covariances, it was not possible to formulate objective prior information;
therefore, it was necessary to regard the previous information on these parameters as
“non-informative” (Table 2). Additionally, for each region in Ecuador, different models
with varied prior information were run (Appendix A-Tables A1 and A2). The two models
were run using three MCMC chains, a burn-in period of 1000 iterations, and another 15,000
iterations. The convergence of each model was evaluated by using density plot, trace
plot, Brooks–Gelman–Rubin (BGR) plot, and autocorrelation plot. Model selection was
carried out according to the criteria previously described in the literature [28,32]. The
measure of the compatibility of the model was verified by the Bayes-p statistic, which
should be as close as possible to 0.50. Substantially different values indicated a lack of
convergence of the model [34]. The deviance information criterion (DIC) guaranteed the
most parsimonious model, and models with a smaller DIC were chosen as an indication of
the probable parameter–space solutions [18].
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Agreement between diagnostic tests: Both the Kappa coefficient and the positive and
negative agreement between the tests were obtained. The Kappa coefficient was calculated
by using cohen.kappa function from the psych Package [39]. The level of agreement was
expressed in terms of indices of positive and negative agreement [40]. Confidence intervals
were calculated as described by Uebersax in 2018 [41].
True prevalence at farm level: A farm was considered positive when at least one animal
tested positive, either to RB (T+1
∣∣ T−2 ) , SAT-EDTA (T−1 ∣∣ T+2 ) or to both tests (T+1 , T+2 ). For
the true prevalence at farm level (π), the results of the Bayesian analysis were used. The
average of the total farm samples was pool size (k) as described by [19], where P is the
brucellosis seroprevalence at herd level.
π = 1− (1− P)
1
k
Risk factors for test seropositivity on farms: Factors investigated were herd size, type
of production (milk, beef and mixed), permanent veterinary control, reproduction system
(artificial insemination, natural breeding, mixed), abortions recorded, and brucellosis
vaccination. Factor influence was determined by using multiple logistic regression. The
final adjusted model was obtained using glm function and stepAIC function from the
MASS package [42] in R environment.
3. Results
3.1. Apparent Prevalence at Animal Level
Apparent prevalence, based on SAT-EDTA and RB results, in addition to parallel
testing, yielded similar results of approximately 2% of animals. Sampled farms with results
from tests and a layer with the provincial administrative country division are presented in
Figure 1. Table 3 presents seroprevalence per study zone.




Figure 1. Farms with and without cases of brucellosis. 
Table 3. Estimations of the apparent prevalence of brucellosis in animals and at the farm level (%) in Ecuador and in the 
Coastal Region, North Highlands, South Highlands, and Amazonia. 




Farm Level * 
True Prevalence (95% 
CI) 
Farm Level * 
Ecuador RB 2.10 (1.72–2.56) 
7.9 (7.0–9.0) 12.2 (7.8–17.9)  SAT-EDTA 2.03 (1.66–2.49) 
 Parallel interpretation 2.20 (1.81–2.67) 
Coastal Region RB 3.29 (2.56–4.22) 
18.6 (15.9–21.7) 28.2 (15.7–39.8)  SAT-EDTA 3.15 (2.44–4.06) 
 Parallel interpretation 3.43 (2.69–4.36) 
Northern Highlands RB 1.97 (1.40–2.78) 
5.8 (4.6–7.3) 5.5 (2.2–9.2)  SAT-EDTA 1.91 (1.33–2.74) 
 Parallel interpretation 2.03 (1.45–2.84) 
Southern Highlands RB 0.23 (0.11–0.49) 
1.2 (0.6–2.4) 0.7 (0.6–2.1)  SAT-EDTA 0.21 (0.09–0.47) 
 Parallel interpretation 0.23 (0.11–0.49) 
Amazon Region RB 1.17 (0.30–4.57) 
4.2 (1.5–9.9) 7.2 (0.9–15.6)  SAT-EDTA 1.44 (0.45–4.68) 
 Parallel interpretation 1.44 (0.45–4.68) 
Legend: A farm is considered positive when it has one or more animals that had positive result on the RB or SAT-EDTA 
test (parallel interpretation). 
  
Figure 1. Farms with and without cases of brucellosis.
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Table 3. Estimations of the apparent prevalence of brucellosis in animals and at the farm level (%) in Ecuador and in the Coastal
Region, North Highlands, South Highlands, and Amazonia.







Ecuador RB 2.10 (1.72–2.56)
7.9 (7.0–9.0) 12.2 (7.8–17.9)SAT-EDTA 2.03 (1.66–2.49)
Parallel interpretation 2.20 (1.81–2.67)
Coastal Region RB 3.29 (2.56–4.22)
18.6 (15.9–21.7) 28.2 (15.7–39.8)SAT-EDTA 3.15 (2.44–4.06)
Parallel interpretation 3.43 (2.69–4.36)
Northern Highlands RB 1.97 (1.40–2.78)
5.8 (4.6–7.3) 5.5 (2.2–9.2)SAT-EDTA 1.91 (1.33–2.74)
Parallel interpretation 2.03 (1.45–2.84)
Southern Highlands RB 0.23 (0.11–0.49)
1.2 (0.6–2.4) 0.7 (0.6–2.1)SAT-EDTA 0.21 (0.09–0.47)
Parallel interpretation 0.23 (0.11–0.49)
Amazon Region RB 1.17 (0.30–4.57)
4.2 (1.5–9.9) 7.2 (0.9–15.6)SAT-EDTA 1.44 (0.45–4.68)
Parallel interpretation 1.44 (0.45–4.68)
Legend: *A farm is considered positive when it has one or more animals that had positive result on the RB or SAT-EDTA test
(parallel interpretation).
3.2. Agreement between Tests
To measure the agreement between the RB and SAT-EDTA, a kappa index of 0.93
(95% CI: 0.92 to 0.95) was obtained. The index of positive agreement was 0.936 (95% CI:
0.910–0.953), and the index of negative agreement was 0.999 (95% CI: 0.998–0.999).
3.3. True Prevalence at Animal Level
The results of the cross classification of the two tests on the 22,126 animals are shown
in Table 4. Of the total of the samples analyzed, 440 were positive to SAT-EDTA, of which
419 were also positive for RB.
Table 4. Cross-classification of the RB and SAT-EDTA test results for cattle brucellosis in Ecuador




T+1 419 36 455
T−1 21 21,650 21,671
Total 440 21,686 22,126
Table 5 presents the Bayesian estimations for parameters obtained, on a national level,
by the two models proposed and their 95% credibility intervals (CrI) with respect to the true
prevalence and test characteristics. Appendix A-Table A3 presents the results by regions.
True prevalence was estimated to be around 1.6% (95% CrI: 1.0–2.3). Furthermore,
there was evidence of spatial variability due to disease prevalence. The Coastal Region had
the highest true prevalence of 2.5% (95% CrI: 1.3–3.8), whilst the Southern Highlands had
the lowest prevalence at the animal level of 0.1% (95% CrI: 0.0–0.3).
In general, both models gave similar results. However, convergence statistics were
favorable to Model 1 (with probabilistic constraints), while BGR values were close to 1. The
trace plot of the chains was mixed correctly, and density plots retained a unimodal and
Gaussian bell shape (Appendix A-Figures A1–A5). Values obtained for Bayes-p and DIC
showed that Model 1 was more parsimonious, since all the Bayes-p values were close to 0.5
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(the values ranged from 0.52 to 0.66) and presented smaller DIC values in comparison to
Model 2 (Table 5 and Appendix A-Tables A2 and A3).
Table 5. Posterior means and 95% credibility intervals (CrI) of the true prevalence and test parameters obtained from two
different models in Ecuador.
Parameter
With and without Vaccination With Vaccination Without Vaccination
Model 1 Model 2
Mean (95% CrI) Mean (95% CrI) Mean (95% CrI) Mean (95% CrI)
TP 1.6% (1.0–2.3%) 1.5% (1.0–2.0%) 2.6% (1.0–4.5%) 1.4% (0.7–2.2%)
SeT1 64.5% (43.1–84.9%) 65.2% (51.9–82.6%) 79.4% (60.4–92.7%) 77.0% (57.0–91.9%)
SpT1 98.9% (98.6–99.0%) 98.9% (98.6–99.0%) 98.1% (96.7–99.7%) 99.6% (99.0–99.9%)
SeT2 62.2% (40.6–84.2%) 63.0% (50.8–81.9%) 80.8% (60.0–95.7%) 77.8% (56.7–94.5%)
SpT2 98.9% (98.6–99.1%) 98.9% (98.6–99.1%) 98.1% (96.6–99.7%) 99.5% (98.9–99.9%)
cov_a 0.176 (0.074–0.234) 0.179 (0.090–0.232) 0.108 (0.006–0.207) 0.123 (0.014–0.220)
cov_b 0.011 (0.010–0.014) 0.010 (0.009–0.013) 0.018 (0.003–0.032) 0.004 (0.000–0.010)
BGR 1.00 1.01 1.01 1.00
Bayes-p 0.55 1.00 0.54 0.52
DIC 21.66 39.63 18.18 19.84
Legend: SeT1 = sensibility of Rose Bengal test; SpT1 = specificity of Rose Bengal test; SeT2 = sensibility of SAT-EDTA test; SpT2 = specificity
of SAT-EDTA test; cov_a = relationship: RB and SAT-EDTA/disease; cov_b = relationship: RB and SAT-EDTA/absence of disease;
BGR = multivariate Brooks–Gelman–Rubin (BGR) statistic; Bayes-p = Bayesian p-values; DIC = deviance information criterion;
CrI = credibility interval.
3.4. Test Characteristics of RB and SAT-EDTA
The sensitivity and specificity estimations for RB and SAT-EDTA were similar in the
two models throughout all regions (see Table 5 and Appendix A-Table A3). RB sensitivity,
however, varied among the regions. On a national level, it was 64.5% (95% CrI: 43.1–84.9),
but it was higher in the Amazon Region with 81.8% (95% CrI: 64.0–94.5), followed by
the Highland Regions with 73.1% (95% CrI: 53.2–89.0), and lowest in the Coastal Region
with 72.4% (95% CrI: 51.4–89.5). Estimations of SAT-EDTA sensitivities in the regions were
slightly lower than the RB. On a national level, it was 62.2% but with wider 95% CrI as
40.6–84.2. Similarly, among the different regions, it reached the highest value in the Amazon
Region where it was 81% (95% CrI: 64.2–93.8), and the lowest sensitivity occurred in the
Southern Highlands, i.e., 59.4% (95% CrI: 33.9–85.5). Overall, the sensitivity estimations
show informative and unimodal posterior distributions. Conversely, specificity estimations
were relatively high (over 98%) for both tests, being 99% in the majority of cases.
The sensitivity and specificity estimations for RB and SAT-EDTA in Ecuador in parallel
testing were, respectively, 67.63% (95% CrI: 45.14–89.53) and 98.81% (95% CrI: 98.51–98.97).
3.5. Relationship between Test Results and the Status of the Disease
The values of the covariants a and b are similar in the two models, as observed
in Table 5 and Appendix A-Table A3. In the case of covariant a (covariance between
tests in infected individuals), it was 0.18 in the whole country, varying from 0.15 in the
Coastal Region to 0.03 in the Southern Highlands, and 0.06 in the Amazon Region. This
positive covariance in the infected individuals has a probabilistic interpretation that can
be calculated P(T+2
∣∣T+1 , D+) by using these covariances. These probabilities were 0.90 for
all of Ecuador, 0.93 for the Coastal Region, 0.88 for the Northern Highlands, 0.75 in the
Southern Highlands, and 0.79 in the Amazon Region. In the last two cases, the tests were
more independent, and conversely, as in the case of the whole country, a positive result
tends to be positive in the second test. Similarly, covariant b (covariance between tests in
uninfected individuals) showed relatively lower values going from 0.002 to 0.01, which in
terms of conditional probabilities ( P(T−2
∣∣T−1 , D−) represented values near 0.98 or higher.
This reflects the high correlation between negative results.
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3.6. Prevalence at Animal Level on Farms with and without Vaccination
Out of 22,126 animals, 4589 belong to farms that were vaccinated previously against
brucellosis. In Ecuador, two types of vaccines, nationally produced Strain 19 and imported
biological RB51, are used in cattle for the prevention of brucellosis. Sixty-six percent of
farms that vaccinated used Strain 19, 18.5% used RB51, and 15.5% do not know which
vaccine they used. The values of true prevalence and diagnostic test characteristics of RB
and SAT-EDTA of vaccinated and unvaccinated animals are shown in Table 5.
3.7. Apparent and True Prevalence at Herd Level
Herd-apparent and true prevalence estimations are shown in Table 3 for both the entire
country, as well as for the different regions. Brucellosis-true prevalence for farms varied
from almost 0.1% in the Southern Highlands to 28% in the Coastal Region. On a national
level, apparent prevalence for farms was 7.9% (95% CI: 7–9), and the true prevalence was
12.2% (95% CI: 7.8–17.9). The average pool sizes (k) for those true prevalence estimates
were k = 8 nationally, k = 13 for the Coastal Region, k = 6 for the Northern Highlands, k = 7
for the Southern Highlands, and k = 9 for the Ecuadorian Amazon Region.
3.8. Risk Factors for Farm Seropositivity
Six variables were significant in the initial selection of variables as potential risk factors
associated with brucellosis seropositivity on farms. These included: farm size, type of
production, veterinary control, reproduction system, abortions recorded, and vaccination
on the farm (Table 6).







Initial Model Final Model
OR (95% CI) p-Value OR (95% CI) p-Value
Farm size Large 264 74 28.0% Reference
Medium 734 84 11.4% 0.462 (0.313–0.681) <0.001 0.457 (0.310–0.671) <0.001
Small 1662 54 3.2% 0.176 (0.110–0.281) <0.001 0.170 (0.107–0.271) <0.001
Type of
production
Beef 234 14 6.0% Reference
Dairy 1782 112 6.3% 1.215 (0.642–2.302) 0.550 1.283 (0.681–2.415) 0.441
Mixed 648 89 13.7% 1.744 (0.919–3.310) 0.089 1.780 (0.939–3.375) 0.077
Vaccination No 2324 133 5.7% Reference
Yes 261 71 27.2% 3.083 (2.129–4.463) <0.001 1.895 (1.375–2.612) <0.001
Veterinary
control
No 1922 128 6.7% Reference
Yes 751 84 11.2% 1.183 (0.840–1.67) 0.336 –
Abortions No 1907 107 5.6% Reference
Yes 730 106 14.5% 1.862 (1.346–2.575) <0.001 3.130 (2.172–4.509) <0.001
Reproduction
system
Insemination 282 36 13.6% Reference
Mixed 301 25 3.4% 0.548 (0.291–1.033) 0.063 –
Natural
breeding 2040 155 9.3% 0.757 (0.474–1.210) 0.245 –
After stepwise process selection, the chosen model was the one with less AIC (1159.19)
that included four risk factors: farm size, type of production, abortions recorded, and
vaccination (Table 6). Medium and small farms were less affected than large farms
(p-value < 0.001): OR = 0.457 (95% CI: 0.310–0.671) and 0.17 (95% CI: 0.107–0.271). Mixed
(milk and beef) and dairy farms were more affected than beef cattle farms with OR = 1.78
(95% CI: 0.939–3.375). Farms that had carried out brucellosis vaccination had a higher
risk (OR = 1.895; 95% CI: 1.375–2.612) than farms without vaccination. Finally, farms with
abortions recorded had a higher risk (OR = 3.13; 95% CI: 2.172–4.509) than farms without
the presence of abortions.
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4. Discussion
Brucellosis is one of the most common zoonoses in the world. It has proven to be a
great problem for public health in developing countries, affecting both humans and animals.
Furthermore, it has generated great economic losses in the livestock industry. Although the
disease produces reproductive problems, many animals remain asymptomatic, so several
diagnostic tests are needed to determine the presence of the disease [1,8,18,43,44].
In this study, a Bayesian approach was used to estimate cattle brucellosis prevalence
and the test characteristics (sensitivity and specificity) of two serological tests [18] by
using two approaches: one based on conditional probabilities [32] and the other based on
covariances between tests [28]. Bayesian approach allowed the incorporation of external
information based on expert opinions and the bibliographic compilation of previous
studies [32,45]. In practice, accessing prior knowledge made it possible to know estimations
of the model parameters. Therefore, prior information should be sought and incorporated
in terms of prior distributions [46,47]. Additionally, the large sample size (22,126 animals)
made a corrective strategy, which allowed the data “to speak for itself” [48]. In this
sense, Model 1 required fewer parameters than Model 2, which would have required
prior knowledge of sensitivities and specificities for both tests. Thus, Model 1 obtained
lower DIC values in all the cases and also obtained better predictive posterior probabilities
(approximately 0.50) in contrast to Model 2, in which Bayes-p values were far from 0.50.
In addition, this research focused on determining the presence of brucellosis on small
and medium cattle farms, since they encompass 86.7% of farms nationwide. Apparent
prevalence was estimated in 2.2% with the TP was 1.6% (95% CrI: 1.0–2.4) at the animal
level and 12.2% at the farm level. The apparent prevalence at the farm level as 7.9% (95%
CI: 7.0–9.0) agreed with results obtained in a study where 2054 animals were sampled.
Indeed, 5.19% (101/2054) were positive for RB and 6.49% (126/2054) positive for SAT-EDTA
(Ron-Román J., 2014, unpublished data). By comparing the true prevalence obtained (1.6%)
with that estimated in 1979 [6] and the one from 2008 (3%) [3], it can be concluded that the
National Program for the Control of Brucellosis implemented by Agrocalidad decreased
the number of cattle infected with bovine brucellosis. However, continued presence of the
disease may be due to the fact that the certification offered is not compulsory. Certification
also tends to be obtained more frequently by large farms, omitting numerous small and
medium farms. Other study mentions that although small producers know about the
dangers of the disease, they will not separate the animals that have been aborted from
the rest of the cattle, since they do not have the necessary physical facilities to isolate sick
or suspicious animals [49]. Additionally, the extra payment offered by participating in
this program (US$0.01 per liter) [25] might not be significant enough to encourage animal
brucellosis testing by small farmers.
Carbonero et al. [4] in a random cross-sectional study took 2666 samples from 386 dairy
and dual-purpose cattle farms in eight provinces of Ecuador (Azuay, Chimborazo, Cotopaxi,
Manabí, Pichincha, Santo Domingo, Tungurahua, and Zamora Chinchipe) analyzed by
using RB test and a blocking ELISA test determined that the true prevalence in Ecuador
is 17% (95% CI: 15.6–18.4%) at the animal level and 45.1% at the farm level. This study
included regional coverage, while in previous years, there were only local studies available
that had been carried out as part of university undergraduate theses research. The results
published by Carbonero [4] differ from those obtained in this study, since the authors took
sensitivity and specificity values provided by the manufacturer. It is currently known that
these values vary due to external factors, as well as according to the field in which they
are applied [32,50–52]. This variation is mainly due to the differences between reference
populations, sampling strategies that have been used for the validation procedure, technical
variation of the tests (distinct laboratories), competence of the laboratory, choice of gold
standard and cut-off value for interpretation and management of results, and the sanitary
conditions of the populations with respect to other conditions [53].
This study found that the areas with the highest true prevalence of brucellosis in
Ecuador are the Coastal Region and Northern Highlands with prevalence levels around
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of 2.5% and 1.0%, respectively, these results maintain the classification given by Torres in
2008 [3], in which the Coastal Region and the Northern Highlands are considered regions
of high prevalence. However, in the Northern Highlands, brucellosis prevalence has
decreased as the main dairy farms are here and receive a bonus of US$0.01 per liter of raw
milk for herds certified as free of brucellosis in order to encourage and promote animal
health in the national dairy herd [54].
In contrast, the Coastal Region had an increase in seroprevalence because the ex-
ploitation of beef and mixed cattle predominates here [55]. Since dairy is not the main
activity, farmers are more reluctant than dairy producers to apply control measures because
they do not benefit from of the brucellosis-free herd bonus [56]. Previous study reported
that beef-producing breeds are 22 times more likely to contract the disease than breeds
dedicated to milk production, since these breeds are usually mobilized without any con-
trol [57]. Furthermore, the mixture of breeds incentivizes the mobilization of animals from
different regions. For example, dairy bulls are transported to tropical zones to improve
milk production. Moreover, extensive farming and low technological development might
have also caused increased brucellosis intensity in that region [58].
The Southern Highlands and Amazon Region presented true prevalence values of 0.1%
and 0.8%, respectively, considered as low-prevalence regions. The Southern Highlands
presented a lower prevalence, probably due to the number of small farms and limited
commercial integration with the epidemiological regions of high prevalence, since the
commercialization of animals is carried out internally in the region [3,6]. In the Amazon
Region, the prevalence is relatively low; however, herds with mixed breeds are prominent
in this region and, as the risk analysis confirmed, more likely to be seropositive [57,59].
In comparing the results of the Northern and Southern Highlands, it can be determined
that the true prevalence is higher in the Northern Highlands due to the high mobility of
allegedly infected animals. This can be contributed to the fact that it is a borderland
with commercial exchange between Ecuador and Colombia [60], a country that records a
seroprevalence of bovine brucellosis of 2.4% to 5% [61].
The risk variables associated with the presence of bovine brucellosis in 2733 herds
sampled in Ecuador were farm size, type of production, abortions recorded, and vaccination
on the farm. The seroprevalence increased significantly with herd size, since large herds
have a higher risk of seropositivity in comparison to the small and medium ones. Certain
characteristics of large herds, such as difficulty of individualized handling of animals
and deficient sanitary control, increases the exposure potential, especially after incidents
of abortions in which there is contact and common feeding at watering points, which
promotes the transmission of Brucella organisms [62–64].
A positive association was found between the presence of previous abortions with
brucellosis seropositivity. This could be explained by the fact that abortion is a typical
outcome in brucellosis-infected animals [63]. Mixed herds (dairy–beef) had a higher risk of
becoming infected than farms with dairy or beef-only herds (OR = 1.78, using beef cattle
as the reference). This is due to the fact that herds of mixed breeds are associated with a
higher number of seropositive cattle in a herd and, because of the mixture, increase animal
mobilization [65].
It can be observed that the true prevalence in vaccinated animals (2.6% with 95%
CrI: 1.0–4.5%) is almost double in comparison with unvaccinated animals (1.4% with 95%
CrI: 0.7–2.2%), indicating that positives are associated with vaccination or the presence of
true positive responses (due to infection) in a context of an unappropriated vaccination
control program on farms. Vaccinating animals with inappropriate doses, at incorrect ages
and unrecommended administration procedures, also represents a risk for abortion or
premature birth, especially when using Strain 19 [66]. The specificity values of the tests
that include unvaccinated animals are higher than in populations where animals have
received vaccination as well as in the general sampling (with and without vaccination).
This is due to the fact that the number of false positives decreases by doing the more
specific tests [51]. However, the specificity does not reach 100%, since false positives may
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also be due to the probable presence of cross reactions such as Yersinia enterocolitica O: 9,
Escherichia coli O: 157, Salmonella group N (O: 30), Vibrio cholerae O1 infections, Scherichia
hermani, or Stenotrophomonas maltophilia [67,68]. Additionally, sensibility and specificity
values of the two serological tests had similar values to the ones previously reported when
this division was not carried out.
However, according to the results, 65% of vaccinated animals have used Strain 19.
This vaccine has a smooth phenotype, making it difficult to distinguish between vaccinated
and naturally infected animals through the use of common serological diagnostic tests,
especially if the vaccination is not exclusively reserved for the young animals [69,70].
Additionally, this vaccine is an alive vaccine that can cause a reaction as described in
goats by [71] and humans [72]. This can also be associated with a poor vaccination system,
especially in rural areas [73]. According to another study, Strain 19 is excreted intermittently
in milk throughout a reproductive cycle in of dairy cows [74]. In addition, Brucella spp.
DNA was detected by multiplex PCR in 37/192 fresh cheese, where 30 samples were
classified as Strain 19 [66], illustrating a real risk to public health.
Although brucellosis prevalence has decreased at both the national and regional levels,
it is important to update the information on the epidemiological status of each region in
order to identify aspects of the brucellosis control program that should be improved or
revamped. Furthermore, this should be accompanied by health education for the producers
and veterinarians regarding biosecurity and efficient vaccination systems, since limited
knowledge makes it impossible to achieve the elimination of the disease in cattle and
humans [56,59,75].
Although there are several studies to determine the cattle-brucellosis prevalence in
Ecuador, there are no studies on the test characteristics (sensitivity and specificity) of the
RB and SAT-EDTA tests. Knowing the true values of Se and Sp will help provide better
diagnosis of the disease by reducing the incorrect classification of infected and uninfected
cattle. This will also prevent unnecessary economic losses when animals are wrongly
classified by tests [76].
The incorporation of SAT-EDTA would increase the quality of the national control
program, since 11% (θ_5) more animals with acute infection may be diagnosed. In this
sense, parallel testing at the beginning of a control program is necessary because it increases
the sensitivity level and helps eliminate true positives more quickly. The combination
of SAT and iELISA (parallel testing) in risk and restricted herds is being used widely in
brucellosis program elsewhere, as it increases the number of diagnosed cases and allows for
follow-up [77,78]. These results suggest that Ecuador should change tests in the national
brucellosis control program for tests capable of detecting different stages of the disease
(IgG and IgM).
According to the results obtained, it can be assumed that the RB and the SAT-EDTA
tests are conditionally dependent on the true animal-health status. This is due to the
fact that both tests may have a similar biological basis and SAT-EDTA might also distin-
guish IgG immunoglobulins in addition to IgM. Therefore, the assumption of conditional
independence is unsustainable due to the similarity of antibodies detected by the two
tests [32,79,80]. In this sense, the results should be highly correlated, and the sensibility
of the combination not increase as much as if they were independent. The concordance
indices of the results of the two tests indicate a high level of agreement. The kappa statistic
was 0.93 (95% CI: 0.92–0.95), a value considered almost perfect as described by Landis and
Koch [81]. In the assessment of the test agreements, the indices of positive and negative
agreement results were 0.936 (95% CI: 0.920–0.953) and 0.999 (95% CI: 0.998–0.999), respec-
tively, which reinforces the aforementioned. In the case of positive results, only 5% of cases
do not agree; in the case of negative results, less than 1% do not agree.
The diagnostic test characteristics at the national level of RB (Se = 64.5% with 95%
CrI: 43.1–84.9; Sp = 98.9% with 95% CrI: 98.6–99.0%) agree with the findings previous
studies [38,45,82]. The sensitivity of SAT-EDTA (62.2%; 95% CrI: 40.6–84.2) and specificity
98.9% (95% CrI: 98.6–99.1%) agree also with the results of previous studies [38,83–85]. The
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results of this investigation varied slightly according to each region where the study was
carried out (Coastal Region, Northern Highlands, Southern Highlands, or Amazon Region)
due to host factors, infectious dose, and distribution of biological factors related to the
infection (stage and severity of the disease) [38,86,87]. Parallel testing strategy presented a
Se of 67.63% (95% CrI: 45.14–89.53) and Sp of 98.81% (95% CrI: 98.51–98.97), which may
be useful for massive testing to reduce brucellosis prevalence at the initial stages of the
control program where high rates of prevalence are reported. Furthermore, this strategy
can be implemented at a relatively low cost, which can be affordable for small and medium
cattle farms.
5. Conclusions
Based on two serological tests of relatively quick implementation and a large-enough
sample size, cattle brucellosis true prevalence was estimated in Ecuador to be around 1.6%
at the animal level and 12% at the farm level. Geographic spatial variations were identified
around the country, the Coastal Region presenting higher prevalence (2.5%). Risk-factor
analysis found that mixed production and the abortions recorded on the farms increased
the risk of cattle brucellosis presence on farms. The true prevalence in vaccinated animals
(2.6% with 95% CrI: 1.0–4.5%) is almost double in comparison with unvaccinated animals
(1.4% with 95% CrI: 0.7–2.2%). The Strain 19 vaccine was used in sixty five percent (65%) of
vaccinated animals.
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Table A1. Prior information used for sensitivity and specificity of RB and SAT and prevalence in the Coastal Region, Northern Highlands, Southern Highlands, and Amazon Region used
in Models 1 and 2.
Region
MODEL 1 MODEL 2
REFERENCES
Parameter Value Distribution Parameter Value Distribution
Coastal Region
theta [1] 4.0% Beta = (9, 193) TP 4% Beta = (9, 193) [3]
theta [2] 66.4–96.0% Beta = (16, 6) SE [1] 66.4–96.0% Beta = (16, 6) [37]
theta [3] 71.0–99.0% Uniform = (0.71, 0.99) SP [1] 71.0–99.0% Uniform = (0.71, 0.99) [37]
theta [4] NI Uniform = (0.00, 1.00) SE [2] 50.0–99.0% Uniform = (0.55, 0.99) [38]
theta [5] NI Uniform = (0.00, 1.00) SP [2] 90.0–100.0% Uniform = (0.90, 1.0) [38]
theta [6] NI Uniform = (0.00, 1.00) a [1] NI Uniform = (0.00, 0.25) -
theta [7] NI Uniform = (0.00, 1.00) b [1] NI Uniform = (−0.25, 0.25) -
Northern Highlands
theta [1] 2.5% Beta = (5, 197) TP 2.5% Beta = (5, 197) [3]
theta [2] 66.4–96.0% Beta = (16, 6) SE [1] 66.4–96.0% Beta = (16, 6) [37]
theta [3] 71–99% Uniform = (0.71, 0.99) SP [1] 71.0–99.0% Uniform = (0.71, 0.99) [37]
theta [4] NI Uniform = (0.70, 1.00) SE [2] 50.0–99.0% Uniform = (0.55, 0.99) [38]
theta [5] NI Uniform = (0.00, 1.00) SP [2] 90.0–100.0% Uniform = (0.90, 1.00) [38]
theta [6] NI Uniform = (0.00, 1.00) a [1] NI Uniform = (0.00, 0.25) -
theta [7] NI Uniform = (0.00, 1.00) b [1] NI Uniform = (−0.25, 0.25) -
Southern Highlands
theta [1] 0.5% Beta = (1, 201) TP 0.5% Beta = (1, 201) [3]
theta [2] 66.4–96.0% Beta = (16, 6) SE [1] 66.4–96.0% Beta = (16, 6) [37]
theta [3] 71.0–99.0% Beta = (20, 2) SP [1] 71.0–99.0% Beta = (20, 2) [37]
theta [4] NI Uniform = (0.40, 1.00) SE [2] 30.0%–90.0% Uniform = (0.30, 0.90) Supposed
theta [5] NI Uniform = (0.00, 0.60) SP [2] 90.0–100.0% Uniform = (0.90, 1.00) [38]
theta [6] NI Uniform = (0.00, 1.00) a [1] NI Uniform = (0.00, 0.25) -
theta [7] NI Uniform = (0.00, 0.60) b [1] NI Uniform = (−0.25, 0.25) -
Amazon Region
theta [1] 1% Beta = (2, 200) TP 1% Beta = (2, 200) [57]
theta [2] 66.4–96.0% Beta = (18, 4) SE [1] 66.4–96.0% Beta = (18, 4) [37]
theta [3] 71.0–99.0% Beta = (21, 1) SP [1] 71.0–99.0% Beta = (21, 1) [37]
theta [4] NI Uniform = (0.80, 1.00) SE [2] 50.0–99.0% Uniform = (0.55, 0.99) [38]
theta [5] NI Uniform = (0.00, 0.60) SP [2] 90.0–100.0% Uniform = (0.90, 1.00) [38]
theta [6] NI Uniform = (0.50, 1.00) a [1] NI Uniform = (0.00, 0.25) -
theta [7] NI Uniform = (0.00, 0.60) b [1] NI Uniform = (−0.25, 0.25) -
Legend: NI = non-informative.
Microorganisms 2021, 9, 1815 17 of 20
Table A2. Prior information used for sensitivity and specificity of RB and SAT and prevalence on farms with and without







theta [1] 3% Beta = (7, 195) [3]
theta [2] 66.4–96.0% Beta = (17, 5) [37]
theta [3] 71.0–99.0% Beta = (20, 2) [37]
theta [4] NI Uniform = (0.00, 1.00) -
theta [5] NI Uniform = (0.00, 1.00) -
theta [6] NI Uniform = (0.00, 1.00) -
theta [7] NI Uniform = (0.00, 1.00) -
Legend: NI = non-informative.
Table A3. Posterior means and 95% credibility intervals (CrI) of the true prevalence and test parameters obtained from two
different models in the Coastal Region, Northern Highlands, Southern Highlands, and Amazon Region.
Region Parameter
Model 1 (%) Model 2 (%)
Mean (CrI) Mean (CrI)
Coastal Region
True prevalence 2.5% (1.3–3.8%) 2.5% (1.5–3.5%)
SeT1 72.4 (51.4–89.5%) 72.6% (58.2–87.5%)
SpT1 98.5 (97.7–99.0%) 98.5% (97.8–99.0%)
SeT2 69.6 (47.8–88.6%) 70.1% (56.3–86.9%)
SpT2 98.6 (97.7–99.1%) 98.6% (97.9–99.1%)
cov_a 0.150 (0.043–0.226) 0.157 (0.060–0.223)





True prevalence 1.0% (0.4–1.7%) 1.0% (0.4–1.6%)
SeT1 73.2% (53.2–89.2%) 72.6% (57.1–87.2%)
SpT1 98.7% (98.2–99.0%) 98.7% (98.2–99.0%)
SeT2 70.8% (48.5–91.2%) 70.4% (56.1–89.6%)
SpT2 98.7% (98.3–99.1%) 98.7% (98.3–99.1%)
cov_a 0.121 (0.005–0.215) 0.128 (0.019–0.214)





Real prevalence 0.1% (0.0–0.3%) 0.1% (0.0–0.2%)
SeT1 73.0% (53.2–88.8%) 71.7% (52.5–87.2%)
SpT1 99.8% (99.6–99.9%) 99.8% (99.7–99.9%)
SeT2 59.4% (33.9–85.5%) 59.7% (32.2–86.7%)
SpT2 99.8% (99.6–99.9%) 99.8% (99.7–99.9%)
cov_a 0.028 (−0.134–0.176) 0.088 (0.005–0.198)





Real prevalence 0.8% (0.1–1.8%) 0.5% (0.1–1.4%)
SeT1 81.8% (64.0–94.5%) 78.8% (61.0–92.4%)
SpT1 99.4% (98.5–100.0%) 99.1% (98.4–99.9%)
SeT2 81.0% (64.2–93.8%) 80.3% (58.2–96.7%)
SpT2 99.2% (98.2–99.8%) 98.9% (98.1–99.7%)
cov_a 0.060 (0.020–0.109) 0.073 (0.003–0.179)




Legend: SeT1 = sensibility of Rose Bengal test; SpT1 = specificity of Rose Bengal test; SeT2 = sensibility of SAT-EDTA test; SpT2 = specificity
of SAT-EDTA test; cov_a = relationship: RB and SAT-EDTA/disease; cov_b = relationship: RB and SAT-EDTA/absence of disease;
BGR = multivariate Brooks–Gelman–Rubin (BGR) statistic; Bayes-p = Bayesian p-values; DIC = deviance information criterion.
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